Lumentum Holdings Inc.LITENASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank31
5Y CAGR-40.6%
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
-40.6%/yr
Long-term compound
Percentile
P31
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20250.56%
2024-1.82%
202339.47%
20220.00%
202111.13%
20207.58%
201917.73%
20185.73%
20175.10%
20160.21%